AXDX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 16:00):

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East...

Stats
Today's Volume	34 996.00
Average Volume	128 024
Market Cap	16.68M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $-0.720 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.160
ATR14	$0.00900 (1.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-17	Phillips Jack	Buy	59 928	Common Stock
2024-04-17	Phillips Jack	Sell	26 735	Common Stock
2024-04-17	Phillips Jack	Sell	59 928	Employee Restricted Stock Units
2024-04-12	Phillips Jack	Buy	59 928	Common Stock
2024-04-12	Phillips Jack	Sell	26 545	Common Stock

INSIDER POWER
96.82
Last 100 transactions
Buy: 51 589 751 \| Sell: 625 027

Volume Correlation

Long: 0.02 (neutral)

Short: 0.70 (moderate)

Signal:(55.933) Neutral

Accelerate Diagnostics Correlation

10 Most Positive Correlations
APOP	0.891
SONM	0.887
EA	0.881
MRACW	0.861
RBNC	0.857
ALIM	0.856
SVOK	0.849
EQRX	0.848
GHVI	0.847
PAIC	0.843

10 Most Negative Correlations
MMAC	-0.943
PKW	-0.908
PID	-0.902
VONV	-0.9
IUSV	-0.896
PVAL	-0.896
LOPE	-0.895
IOSP	-0.894
TCFC	-0.892
RNDV	-0.89

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Accelerate Diagnostics Correlation - Currency/Commodity

-0.71
( moderate negative )

-0.75
( moderate negative )

0.00
( neutral )

0.57
( weak )

0.00
( neutral )

0.27
( neutral )

Accelerate Diagnostics Financials

Annual	2023
Revenue:	$12.06M
Gross Profit:	$2.55M (21.15 %)
EPS:	$-4.94

Q4	2023
Revenue:	$3.00M
Gross Profit:	$606 000 (20.20 %)
EPS:	$-0.890

Q3	2023
Revenue:	$3.30M
Gross Profit:	$107 000 (3.24 %)
EPS:	$0.0630

Q2	2023
Revenue:	$2.92M
Gross Profit:	$799 000 (27.35 %)
EPS:	$-2.36

Financial Reports:

No articles found.

Accelerate Diagnostics

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.